Task Force Established During International Meeting on Breast Cancer in the Developing World

Once thought to be a disease that strikes primarily affluent women in industrialized countries, breast cancer is emerging as a significant problem in developing countries. Among young women in particular, the disease is one of the principal causes of death in middle-income nations. Further, case fatality rates are inversely related to the level of development of countries.  Diagnosis in late stages is much more common than in wealthier nations, making treatment ­— when available — much less effective.

To draw attention to the under-recognized and growing problem, a Harvard-led team of experts convened a multi-day meeting of approximately 400 oncologists, public health experts, advocates, and international figures from 37 countries, November 3 to 5, in Boston.

HSPH Principal Investigators and Staff Respond to Research Transformation Project Survey

Dean Julio Frenk recently initiated the Research Transformation Project to review and innovate research administration at the School. The project, co-chaired by Associate Dean for Research Karen Emmons and Chief Financial and Administrative Officer Laura Ketchum, is examining the School’s current research administration structure, with the goal of achieving outstanding support for the School’s sponsored research portfolio. A working group of 13 faculty and staff from across the School is working closely with the co-chairs.

WEBCAST: Health and Industry Perspectives on Flu Vaccines

Klaus Stohr, Vice President, Global Head, Influenza Strategy at Novartis Vaccines and Diagnostics in Cambridge, MA, spoke to an HSPH audience on October 27.